nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—Gastrointestinal toxicity—Lomustine—brain cancer	0.0296	0.123	CcSEcCtD
Vorinostat—Ureteric obstruction—Hydroxyurea—brain cancer	0.0145	0.0605	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Carmustine—brain cancer	0.0117	0.0489	CcSEcCtD
Vorinostat—Myelosuppression—Lomustine—brain cancer	0.0103	0.0431	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Etoposide—brain cancer	0.00908	0.0378	CcSEcCtD
Vorinostat—NCOR1—hindbrain—brain cancer	0.00832	0.0356	CbGeAlD
Vorinostat—HDAC2—telencephalic ventricle—brain cancer	0.00712	0.0305	CbGeAlD
Vorinostat—HDAC1—hindbrain—brain cancer	0.00668	0.0286	CbGeAlD
Vorinostat—HDAC6—telencephalon—brain cancer	0.00564	0.0242	CbGeAlD
Vorinostat—Myelosuppression—Hydroxyurea—brain cancer	0.00509	0.0212	CcSEcCtD
Vorinostat—HDAC2—Teniposide—Etoposide—brain cancer	0.00499	1	CbGdCrCtD
Vorinostat—HDAC4—telencephalon—brain cancer	0.00486	0.0208	CbGeAlD
Vorinostat—NCOR1—brainstem—brain cancer	0.00477	0.0204	CbGeAlD
Vorinostat—HDAC11—telencephalon—brain cancer	0.00436	0.0187	CbGeAlD
Vorinostat—NCOR1—telencephalon—brain cancer	0.00423	0.0181	CbGeAlD
Vorinostat—Myelosuppression—Carmustine—brain cancer	0.00411	0.0171	CcSEcCtD
Vorinostat—HDAC8—pituitary gland—brain cancer	0.00407	0.0174	CbGeAlD
Vorinostat—HDAC4—gonad—brain cancer	0.00406	0.0174	CbGeAlD
Vorinostat—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00406	0.0169	CcSEcCtD
Vorinostat—Myelosuppression—Temozolomide—brain cancer	0.00397	0.0165	CcSEcCtD
Vorinostat—HDAC1—brainstem—brain cancer	0.00383	0.0164	CbGeAlD
Vorinostat—HDAC3—telencephalon—brain cancer	0.00371	0.0159	CbGeAlD
Vorinostat—HDAC11—gonad—brain cancer	0.00364	0.0156	CbGeAlD
Vorinostat—Neoplasm malignant—Procarbazine—brain cancer	0.00361	0.015	CcSEcCtD
Vorinostat—Lethargy—Lomustine—brain cancer	0.00359	0.015	CcSEcCtD
Vorinostat—HDAC6—endocrine gland—brain cancer	0.00356	0.0152	CbGeAlD
Vorinostat—HDAC11—pituitary gland—brain cancer	0.00355	0.0152	CbGeAlD
Vorinostat—NCOR1—gonad—brain cancer	0.00353	0.0151	CbGeAlD
Vorinostat—HDAC6—head—brain cancer	0.00351	0.015	CbGeAlD
Vorinostat—HDAC4—midbrain—brain cancer	0.00349	0.015	CbGeAlD
Vorinostat—HDAC11—medulla oblongata—brain cancer	0.00343	0.0147	CbGeAlD
Vorinostat—HDAC1—telencephalon—brain cancer	0.0034	0.0146	CbGeAlD
Vorinostat—HDAC2—hindbrain—brain cancer	0.00336	0.0144	CbGeAlD
Vorinostat—HDAC9—telencephalon—brain cancer	0.00334	0.0143	CbGeAlD
Vorinostat—NR0B1—gonad—brain cancer	0.00332	0.0142	CbGeAlD
Vorinostat—NR0B1—pituitary gland—brain cancer	0.00324	0.0139	CbGeAlD
Vorinostat—HDAC6—central nervous system—brain cancer	0.00321	0.0137	CbGeAlD
Vorinostat—Myelosuppression—Etoposide—brain cancer	0.00318	0.0132	CcSEcCtD
Vorinostat—HDAC6—cerebellum—brain cancer	0.00313	0.0134	CbGeAlD
Vorinostat—HDAC11—midbrain—brain cancer	0.00313	0.0134	CbGeAlD
Vorinostat—HDAC4—endocrine gland—brain cancer	0.00307	0.0131	CbGeAlD
Vorinostat—Deep vein thrombosis—Temozolomide—brain cancer	0.00306	0.0128	CcSEcCtD
Vorinostat—HDAC11—spinal cord—brain cancer	0.00306	0.0131	CbGeAlD
Vorinostat—HDAC4—head—brain cancer	0.00303	0.013	CbGeAlD
Vorinostat—HDAC3—pituitary gland—brain cancer	0.00302	0.0129	CbGeAlD
Vorinostat—HDAC3—medulla oblongata—brain cancer	0.00292	0.0125	CbGeAlD
Vorinostat—Embolism—Temozolomide—brain cancer	0.0029	0.0121	CcSEcCtD
Vorinostat—Pancytopenia—Lomustine—brain cancer	0.00289	0.012	CcSEcCtD
Vorinostat—HDAC1—gonad—brain cancer	0.00284	0.0121	CbGeAlD
Vorinostat—HDAC8—cerebellum—brain cancer	0.00278	0.0119	CbGeAlD
Vorinostat—HDAC1—pituitary gland—brain cancer	0.00277	0.0119	CbGeAlD
Vorinostat—HDAC4—central nervous system—brain cancer	0.00276	0.0118	CbGeAlD
Vorinostat—HDAC11—endocrine gland—brain cancer	0.00275	0.0118	CbGeAlD
Vorinostat—HDAC11—head—brain cancer	0.00272	0.0116	CbGeAlD
Vorinostat—HDAC4—cerebellum—brain cancer	0.0027	0.0116	CbGeAlD
Vorinostat—HDAC1—medulla oblongata—brain cancer	0.00267	0.0114	CbGeAlD
Vorinostat—NCOR1—endocrine gland—brain cancer	0.00267	0.0114	CbGeAlD
Vorinostat—HDAC3—midbrain—brain cancer	0.00266	0.0114	CbGeAlD
Vorinostat—NCOR1—head—brain cancer	0.00264	0.0113	CbGeAlD
Vorinostat—HDAC3—spinal cord—brain cancer	0.0026	0.0111	CbGeAlD
Vorinostat—HDAC6—brain—brain cancer	0.00255	0.0109	CbGeAlD
Vorinostat—NR0B1—endocrine gland—brain cancer	0.00251	0.0107	CbGeAlD
Vorinostat—HDAC11—central nervous system—brain cancer	0.00248	0.0106	CbGeAlD
Vorinostat—HDAC1—midbrain—brain cancer	0.00244	0.0105	CbGeAlD
Vorinostat—Abscess—Carmustine—brain cancer	0.00244	0.0101	CcSEcCtD
Vorinostat—HDAC11—cerebellum—brain cancer	0.00242	0.0104	CbGeAlD
Vorinostat—NCOR1—central nervous system—brain cancer	0.00241	0.0103	CbGeAlD
Vorinostat—HDAC9—midbrain—brain cancer	0.0024	0.0103	CbGeAlD
Vorinostat—HDAC1—spinal cord—brain cancer	0.00238	0.0102	CbGeAlD
Vorinostat—NCOR1—cerebellum—brain cancer	0.00235	0.0101	CbGeAlD
Vorinostat—HDAC3—endocrine gland—brain cancer	0.00234	0.01	CbGeAlD
Vorinostat—HDAC3—head—brain cancer	0.00231	0.0099	CbGeAlD
Vorinostat—Lethargy—Procarbazine—brain cancer	0.00228	0.00951	CcSEcCtD
Vorinostat—HDAC8—brain—brain cancer	0.00226	0.00967	CbGeAlD
Vorinostat—HDAC4—brain—brain cancer	0.00219	0.0094	CbGeAlD
Vorinostat—Alopecia—Lomustine—brain cancer	0.00215	0.00897	CcSEcCtD
Vorinostat—HDAC1—endocrine gland—brain cancer	0.00214	0.00918	CbGeAlD
Vorinostat—HDAC1—head—brain cancer	0.00212	0.00906	CbGeAlD
Vorinostat—HDAC3—central nervous system—brain cancer	0.00211	0.00903	CbGeAlD
Vorinostat—HDAC9—head—brain cancer	0.00208	0.00891	CbGeAlD
Vorinostat—HDAC3—cerebellum—brain cancer	0.00206	0.00883	CbGeAlD
Vorinostat—HDAC11—brain—brain cancer	0.00197	0.00843	CbGeAlD
Vorinostat—Infection—Carboplatin—brain cancer	0.00197	0.00819	CcSEcCtD
Vorinostat—HDAC1—central nervous system—brain cancer	0.00193	0.00827	CbGeAlD
Vorinostat—Pulmonary embolism—Carmustine—brain cancer	0.00193	0.00803	CcSEcCtD
Vorinostat—HDAC2—brainstem—brain cancer	0.00193	0.00825	CbGeAlD
Vorinostat—NCOR1—brain—brain cancer	0.00191	0.00818	CbGeAlD
Vorinostat—HDAC9—central nervous system—brain cancer	0.0019	0.00814	CbGeAlD
Vorinostat—Leukopenia—Lomustine—brain cancer	0.0019	0.00791	CcSEcCtD
Vorinostat—HDAC1—cerebellum—brain cancer	0.00189	0.00809	CbGeAlD
Vorinostat—Pulmonary embolism—Temozolomide—brain cancer	0.00186	0.00776	CcSEcCtD
Vorinostat—HDAC9—cerebellum—brain cancer	0.00186	0.00795	CbGeAlD
Vorinostat—Pancytopenia—Procarbazine—brain cancer	0.00184	0.00765	CcSEcCtD
Vorinostat—NR0B1—brain—brain cancer	0.00179	0.00768	CbGeAlD
Vorinostat—Infection—Lomustine—brain cancer	0.00172	0.00716	CcSEcCtD
Vorinostat—HDAC2—telencephalon—brain cancer	0.00171	0.00732	CbGeAlD
Vorinostat—Thrombocytopenia—Lomustine—brain cancer	0.0017	0.00706	CcSEcCtD
Vorinostat—HDAC3—brain—brain cancer	0.00167	0.00717	CbGeAlD
Vorinostat—Sepsis—Carmustine—brain cancer	0.00167	0.00697	CcSEcCtD
Vorinostat—Anorexia—Lomustine—brain cancer	0.00165	0.00687	CcSEcCtD
Vorinostat—Blood creatinine increased—Hydroxyurea—brain cancer	0.00162	0.00675	CcSEcCtD
Vorinostat—Body temperature increased—Carboplatin—brain cancer	0.00156	0.00652	CcSEcCtD
Vorinostat—HDAC1—brain—brain cancer	0.00153	0.00657	CbGeAlD
Vorinostat—HDAC9—brain—brain cancer	0.00151	0.00646	CbGeAlD
Vorinostat—Decreased appetite—Lomustine—brain cancer	0.00151	0.00627	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Temozolomide—brain cancer	0.00143	0.00597	CcSEcCtD
Vorinostat—HDAC2—gonad—brain cancer	0.00143	0.00611	CbGeAlD
Vorinostat—Pancytopenia—Hydroxyurea—brain cancer	0.00142	0.00592	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.0014	0.00583	CcSEcCtD
Vorinostat—Neutropenia—Hydroxyurea—brain cancer	0.0014	0.00583	CcSEcCtD
Vorinostat—HDAC2—pituitary gland—brain cancer	0.00139	0.00596	CbGeAlD
Vorinostat—Chills—Procarbazine—brain cancer	0.00139	0.00578	CcSEcCtD
Vorinostat—Body temperature increased—Lomustine—brain cancer	0.00137	0.0057	CcSEcCtD
Vorinostat—Alopecia—Procarbazine—brain cancer	0.00137	0.00569	CcSEcCtD
Vorinostat—HDAC2—medulla oblongata—brain cancer	0.00134	0.00575	CbGeAlD
Vorinostat—Sepsis—Etoposide—brain cancer	0.00129	0.00539	CcSEcCtD
Vorinostat—Hypokalaemia—Carmustine—brain cancer	0.00127	0.0053	CcSEcCtD
Vorinostat—Dehydration—Temozolomide—brain cancer	0.00126	0.00524	CcSEcCtD
Vorinostat—Anaemia—Procarbazine—brain cancer	0.00124	0.00518	CcSEcCtD
Vorinostat—Hypokalaemia—Temozolomide—brain cancer	0.00123	0.00513	CcSEcCtD
Vorinostat—HDAC2—midbrain—brain cancer	0.00123	0.00526	CbGeAlD
Vorinostat—Syncope—Procarbazine—brain cancer	0.00121	0.00503	CcSEcCtD
Vorinostat—Leukopenia—Procarbazine—brain cancer	0.00121	0.00502	CcSEcCtD
Vorinostat—Loss of consciousness—Procarbazine—brain cancer	0.00118	0.00493	CcSEcCtD
Vorinostat—Cough—Procarbazine—brain cancer	0.00118	0.00489	CcSEcCtD
Vorinostat—Pancytopenia—Carmustine—brain cancer	0.00115	0.00478	CcSEcCtD
Vorinostat—Neutropenia—Carmustine—brain cancer	0.00113	0.00471	CcSEcCtD
Vorinostat—Dry mouth—Procarbazine—brain cancer	0.00112	0.00467	CcSEcCtD
Vorinostat—Pancytopenia—Temozolomide—brain cancer	0.00111	0.00462	CcSEcCtD
Vorinostat—Vomiting—Lomustine—brain cancer	0.0011	0.00458	CcSEcCtD
Vorinostat—Neutropenia—Temozolomide—brain cancer	0.00109	0.00455	CcSEcCtD
Vorinostat—Infection—Procarbazine—brain cancer	0.00109	0.00455	CcSEcCtD
Vorinostat—Hyperglycaemia—Carmustine—brain cancer	0.00109	0.00454	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Temozolomide—brain cancer	0.00109	0.00452	CcSEcCtD
Vorinostat—Shock—Procarbazine—brain cancer	0.00108	0.0045	CcSEcCtD
Vorinostat—HDAC2—endocrine gland—brain cancer	0.00108	0.00462	CbGeAlD
Vorinostat—Thrombocytopenia—Procarbazine—brain cancer	0.00108	0.00448	CcSEcCtD
Vorinostat—Chills—Hydroxyurea—brain cancer	0.00107	0.00447	CcSEcCtD
Vorinostat—HDAC2—head—brain cancer	0.00106	0.00456	CbGeAlD
Vorinostat—Alopecia—Hydroxyurea—brain cancer	0.00106	0.00441	CcSEcCtD
Vorinostat—Weight decreased—Temozolomide—brain cancer	0.00106	0.0044	CcSEcCtD
Vorinostat—Hyperglycaemia—Temozolomide—brain cancer	0.00105	0.00439	CcSEcCtD
Vorinostat—Anorexia—Procarbazine—brain cancer	0.00105	0.00436	CcSEcCtD
Vorinostat—Nausea—Lomustine—brain cancer	0.00103	0.00428	CcSEcCtD
Vorinostat—HDAC2—central nervous system—brain cancer	0.000971	0.00416	CbGeAlD
Vorinostat—Anaemia—Hydroxyurea—brain cancer	0.000963	0.00401	CcSEcCtD
Vorinostat—Decreased appetite—Procarbazine—brain cancer	0.000956	0.00398	CcSEcCtD
Vorinostat—Oedema peripheral—Carmustine—brain cancer	0.000954	0.00397	CcSEcCtD
Vorinostat—HDAC2—cerebellum—brain cancer	0.000949	0.00407	CbGeAlD
Vorinostat—Fatigue—Procarbazine—brain cancer	0.000948	0.00395	CcSEcCtD
Vorinostat—Constipation—Procarbazine—brain cancer	0.00094	0.00391	CcSEcCtD
Vorinostat—Leukopenia—Hydroxyurea—brain cancer	0.000933	0.00389	CcSEcCtD
Vorinostat—Oedema peripheral—Temozolomide—brain cancer	0.000922	0.00384	CcSEcCtD
Vorinostat—Pancytopenia—Etoposide—brain cancer	0.000888	0.0037	CcSEcCtD
Vorinostat—Neutropenia—Etoposide—brain cancer	0.000874	0.00364	CcSEcCtD
Vorinostat—Body temperature increased—Procarbazine—brain cancer	0.000869	0.00362	CcSEcCtD
Vorinostat—Alopecia—Carmustine—brain cancer	0.000855	0.00356	CcSEcCtD
Vorinostat—Infection—Hydroxyurea—brain cancer	0.000845	0.00352	CcSEcCtD
Vorinostat—Chills—Temozolomide—brain cancer	0.000839	0.0035	CcSEcCtD
Vorinostat—Thrombocytopenia—Hydroxyurea—brain cancer	0.000833	0.00347	CcSEcCtD
Vorinostat—Alopecia—Temozolomide—brain cancer	0.000827	0.00344	CcSEcCtD
Vorinostat—Acute coronary syndrome—Etoposide—brain cancer	0.000822	0.00342	CcSEcCtD
Vorinostat—Myocardial infarction—Etoposide—brain cancer	0.000817	0.0034	CcSEcCtD
Vorinostat—Anorexia—Hydroxyurea—brain cancer	0.000811	0.00338	CcSEcCtD
Vorinostat—Dysgeusia—Temozolomide—brain cancer	0.000797	0.00332	CcSEcCtD
Vorinostat—Asthenia—Procarbazine—brain cancer	0.000789	0.00328	CcSEcCtD
Vorinostat—Anaemia—Carmustine—brain cancer	0.000779	0.00324	CcSEcCtD
Vorinostat—Pruritus—Procarbazine—brain cancer	0.000778	0.00324	CcSEcCtD
Vorinostat—HDAC2—brain—brain cancer	0.000771	0.0033	CbGeAlD
Vorinostat—Leukopenia—Carmustine—brain cancer	0.000754	0.00314	CcSEcCtD
Vorinostat—Anaemia—Temozolomide—brain cancer	0.000753	0.00313	CcSEcCtD
Vorinostat—Diarrhoea—Procarbazine—brain cancer	0.000752	0.00313	CcSEcCtD
Vorinostat—Angioedema—Temozolomide—brain cancer	0.000744	0.0031	CcSEcCtD
Vorinostat—Decreased appetite—Hydroxyurea—brain cancer	0.00074	0.00308	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000734	0.00306	CcSEcCtD
Vorinostat—Fatigue—Hydroxyurea—brain cancer	0.000733	0.00305	CcSEcCtD
Vorinostat—Leukopenia—Temozolomide—brain cancer	0.000729	0.00304	CcSEcCtD
Vorinostat—Constipation—Hydroxyurea—brain cancer	0.000727	0.00303	CcSEcCtD
Vorinostat—Dizziness—Procarbazine—brain cancer	0.000727	0.00303	CcSEcCtD
Vorinostat—Chest pain—Carmustine—brain cancer	0.000717	0.00299	CcSEcCtD
Vorinostat—Cough—Temozolomide—brain cancer	0.000711	0.00296	CcSEcCtD
Vorinostat—Vomiting—Procarbazine—brain cancer	0.000699	0.00291	CcSEcCtD
Vorinostat—Headache—Procarbazine—brain cancer	0.000689	0.00287	CcSEcCtD
Vorinostat—Infection—Carmustine—brain cancer	0.000683	0.00285	CcSEcCtD
Vorinostat—Dry mouth—Temozolomide—brain cancer	0.000678	0.00282	CcSEcCtD
Vorinostat—Thrombocytopenia—Carmustine—brain cancer	0.000673	0.0028	CcSEcCtD
Vorinostat—Body temperature increased—Hydroxyurea—brain cancer	0.000673	0.0028	CcSEcCtD
Vorinostat—Chills—Etoposide—brain cancer	0.000672	0.0028	CcSEcCtD
Vorinostat—Alopecia—Etoposide—brain cancer	0.000661	0.00275	CcSEcCtD
Vorinostat—Infection—Temozolomide—brain cancer	0.00066	0.00275	CcSEcCtD
Vorinostat—Anorexia—Carmustine—brain cancer	0.000656	0.00273	CcSEcCtD
Vorinostat—Nausea—Procarbazine—brain cancer	0.000653	0.00272	CcSEcCtD
Vorinostat—Thrombocytopenia—Temozolomide—brain cancer	0.000651	0.00271	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—brain cancer	0.000638	0.00266	CcSEcCtD
Vorinostat—Anorexia—Temozolomide—brain cancer	0.000634	0.00264	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—brain cancer	0.000626	0.00261	CcSEcCtD
Vorinostat—Asthenia—Hydroxyurea—brain cancer	0.00061	0.00254	CcSEcCtD
Vorinostat—Anaemia—Etoposide—brain cancer	0.000602	0.00251	CcSEcCtD
Vorinostat—Decreased appetite—Carmustine—brain cancer	0.000598	0.00249	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Carmustine—brain cancer	0.000594	0.00247	CcSEcCtD
Vorinostat—Constipation—Carmustine—brain cancer	0.000588	0.00245	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—brain cancer	0.000583	0.00243	CcSEcCtD
Vorinostat—Diarrhoea—Hydroxyurea—brain cancer	0.000582	0.00242	CcSEcCtD
Vorinostat—Decreased appetite—Temozolomide—brain cancer	0.000578	0.00241	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Temozolomide—brain cancer	0.000574	0.00239	CcSEcCtD
Vorinostat—Fatigue—Temozolomide—brain cancer	0.000573	0.00239	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—brain cancer	0.000573	0.00239	CcSEcCtD
Vorinostat—Cough—Etoposide—brain cancer	0.000569	0.00237	CcSEcCtD
Vorinostat—Constipation—Temozolomide—brain cancer	0.000568	0.00237	CcSEcCtD
Vorinostat—Dizziness—Hydroxyurea—brain cancer	0.000563	0.00234	CcSEcCtD
Vorinostat—Chest pain—Etoposide—brain cancer	0.000555	0.00231	CcSEcCtD
Vorinostat—Body temperature increased—Carmustine—brain cancer	0.000544	0.00226	CcSEcCtD
Vorinostat—Vomiting—Hydroxyurea—brain cancer	0.000541	0.00225	CcSEcCtD
Vorinostat—Headache—Hydroxyurea—brain cancer	0.000533	0.00222	CcSEcCtD
Vorinostat—Infection—Etoposide—brain cancer	0.000528	0.0022	CcSEcCtD
Vorinostat—Body temperature increased—Temozolomide—brain cancer	0.000525	0.00219	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—brain cancer	0.000521	0.00217	CcSEcCtD
Vorinostat—Anorexia—Etoposide—brain cancer	0.000507	0.00211	CcSEcCtD
Vorinostat—Nausea—Hydroxyurea—brain cancer	0.000505	0.0021	CcSEcCtD
Vorinostat—Asthenia—Carmustine—brain cancer	0.000493	0.00206	CcSEcCtD
Vorinostat—Asthenia—Temozolomide—brain cancer	0.000477	0.00199	CcSEcCtD
Vorinostat—Diarrhoea—Carmustine—brain cancer	0.000471	0.00196	CcSEcCtD
Vorinostat—Pruritus—Temozolomide—brain cancer	0.00047	0.00196	CcSEcCtD
Vorinostat—Decreased appetite—Etoposide—brain cancer	0.000462	0.00193	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—brain cancer	0.000459	0.00191	CcSEcCtD
Vorinostat—Fatigue—Etoposide—brain cancer	0.000459	0.00191	CcSEcCtD
Vorinostat—Dizziness—Carmustine—brain cancer	0.000455	0.00189	CcSEcCtD
Vorinostat—Constipation—Etoposide—brain cancer	0.000455	0.00189	CcSEcCtD
Vorinostat—Diarrhoea—Temozolomide—brain cancer	0.000455	0.00189	CcSEcCtD
Vorinostat—Dizziness—Temozolomide—brain cancer	0.000439	0.00183	CcSEcCtD
Vorinostat—Vomiting—Carmustine—brain cancer	0.000437	0.00182	CcSEcCtD
Vorinostat—Headache—Carmustine—brain cancer	0.000431	0.00179	CcSEcCtD
Vorinostat—Vomiting—Temozolomide—brain cancer	0.000423	0.00176	CcSEcCtD
Vorinostat—Body temperature increased—Etoposide—brain cancer	0.00042	0.00175	CcSEcCtD
Vorinostat—Headache—Temozolomide—brain cancer	0.000416	0.00173	CcSEcCtD
Vorinostat—Nausea—Carmustine—brain cancer	0.000408	0.0017	CcSEcCtD
Vorinostat—Nausea—Temozolomide—brain cancer	0.000395	0.00164	CcSEcCtD
Vorinostat—Asthenia—Etoposide—brain cancer	0.000382	0.00159	CcSEcCtD
Vorinostat—Pruritus—Etoposide—brain cancer	0.000376	0.00157	CcSEcCtD
Vorinostat—Diarrhoea—Etoposide—brain cancer	0.000364	0.00152	CcSEcCtD
Vorinostat—Dizziness—Etoposide—brain cancer	0.000352	0.00146	CcSEcCtD
Vorinostat—Vomiting—Etoposide—brain cancer	0.000338	0.00141	CcSEcCtD
Vorinostat—Headache—Etoposide—brain cancer	0.000333	0.00139	CcSEcCtD
Vorinostat—Nausea—Etoposide—brain cancer	0.000316	0.00132	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—PDGFRA—brain cancer	4.62e-05	8.87e-05	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—VEGFA—brain cancer	4.59e-05	8.81e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOTCH2—brain cancer	4.59e-05	8.81e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—CTNNB1—brain cancer	4.59e-05	8.8e-05	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—STAT3—brain cancer	4.55e-05	8.72e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SHH—brain cancer	4.54e-05	8.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—SIRT1—brain cancer	4.5e-05	8.63e-05	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—EGFR—brain cancer	4.5e-05	8.63e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IRS2—brain cancer	4.5e-05	8.62e-05	CbGpPWpGaD
Vorinostat—NCOR1—Generic Transcription Pathway—MYC—brain cancer	4.49e-05	8.61e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IRS2—brain cancer	4.49e-05	8.61e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—SPP1—brain cancer	4.49e-05	8.61e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HES1—brain cancer	4.48e-05	8.6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ABR—brain cancer	4.46e-05	8.55e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CCND1—brain cancer	4.45e-05	8.53e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—APC—brain cancer	4.42e-05	8.48e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—ERBB2—brain cancer	4.4e-05	8.43e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VAV1—brain cancer	4.38e-05	8.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TRPC6—brain cancer	4.38e-05	8.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—IL2—brain cancer	4.32e-05	8.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GLI2—brain cancer	4.3e-05	8.25e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTCH1—brain cancer	4.3e-05	8.25e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SMO—brain cancer	4.3e-05	8.25e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PDGFRA—brain cancer	4.27e-05	8.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOTCH2—brain cancer	4.22e-05	8.09e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HES1—brain cancer	4.19e-05	8.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ENO2—brain cancer	4.18e-05	8.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SHH—brain cancer	4.18e-05	8.01e-05	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—TP53—brain cancer	4.16e-05	7.98e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SPP1—brain cancer	4.14e-05	7.95e-05	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—EGFR—brain cancer	4.13e-05	7.93e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IRS2—brain cancer	4.13e-05	7.92e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IRS2—brain cancer	4.06e-05	7.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GLI1—brain cancer	4.05e-05	7.76e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HES1—brain cancer	4.03e-05	7.73e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VAV1—brain cancer	4.02e-05	7.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—DNMT1—brain cancer	4.01e-05	7.69e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—STAT3—brain cancer	4e-05	7.67e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PDGFRA—brain cancer	3.99e-05	7.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CCND1—brain cancer	3.98e-05	7.63e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—ERBB2—brain cancer	3.98e-05	7.62e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—APC—brain cancer	3.97e-05	7.61e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—APC—brain cancer	3.96e-05	7.6e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CG—brain cancer	3.96e-05	7.6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CG—brain cancer	3.96e-05	7.59e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SPP1—brain cancer	3.87e-05	7.43e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—CTNNB1—brain cancer	3.85e-05	7.38e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SUFU—brain cancer	3.84e-05	7.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PDGFRA—brain cancer	3.84e-05	7.36e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HES1—brain cancer	3.77e-05	7.22e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IRS2—brain cancer	3.75e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—TP53—brain cancer	3.74e-05	7.18e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—MYC—brain cancer	3.72e-05	7.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GFAP—brain cancer	3.7e-05	7.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—STAT3—brain cancer	3.7e-05	7.1e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—RELA—brain cancer	3.7e-05	7.09e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—VEGFA—brain cancer	3.67e-05	7.05e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—ERBB2—brain cancer	3.67e-05	7.05e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—ERBB2—brain cancer	3.67e-05	7.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Generic Transcription Pathway—MYC—brain cancer	3.66e-05	7.02e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—APC—brain cancer	3.65e-05	7e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—EGFR—brain cancer	3.64e-05	6.97e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—ESR2—brain cancer	3.6e-05	6.91e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—APC—brain cancer	3.59e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PDGFRA—brain cancer	3.59e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CG—brain cancer	3.59e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—MYC—brain cancer	3.57e-05	6.84e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HEY1—brain cancer	3.51e-05	6.73e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IRS2—brain cancer	3.5e-05	6.72e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SPP1—brain cancer	3.48e-05	6.68e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CTNNB1—brain cancer	3.48e-05	6.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HES1—brain cancer	3.46e-05	6.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—DLL1—brain cancer	3.44e-05	6.6e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOTCH2—brain cancer	3.44e-05	6.6e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—ERBB2—brain cancer	3.43e-05	6.58e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NOTCH2—brain cancer	3.41e-05	6.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IRS2—brain cancer	3.37e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—EGFR—brain cancer	3.36e-05	6.45e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—STAT3—brain cancer	3.35e-05	6.43e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL2—brain cancer	3.33e-05	6.39e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CG—brain cancer	3.32e-05	6.38e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—APC—brain cancer	3.31e-05	6.35e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CG—brain cancer	3.31e-05	6.35e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PDGFRA—brain cancer	3.29e-05	6.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VAV1—brain cancer	3.28e-05	6.29e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CCND1—brain cancer	3.25e-05	6.22e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CTNNB1—brain cancer	3.21e-05	6.16e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CTNNB1—brain cancer	3.21e-05	6.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SPP1—brain cancer	3.2e-05	6.13e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MYC—brain cancer	3.19e-05	6.12e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IRS2—brain cancer	3.15e-05	6.04e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—MYC—brain cancer	3.12e-05	5.97e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—RELA—brain cancer	3.1e-05	5.94e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—APC—brain cancer	3.09e-05	5.94e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CG—brain cancer	3.09e-05	5.94e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—ERBB2—brain cancer	3.08e-05	5.91e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—ERBB2—brain cancer	3.08e-05	5.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CG—brain cancer	3.06e-05	5.86e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—EGFR—brain cancer	3.05e-05	5.84e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—STAT3—brain cancer	3.03e-05	5.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—VAV1—brain cancer	3.02e-05	5.79e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CTNNB1—brain cancer	3e-05	5.76e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—APC—brain cancer	2.97e-05	5.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SHH—brain cancer	2.93e-05	5.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SIRT1—brain cancer	2.9e-05	5.56e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IRS2—brain cancer	2.89e-05	5.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—ERBB2—brain cancer	2.83e-05	5.43e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—VEGFA—brain cancer	2.83e-05	5.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TRPC6—brain cancer	2.82e-05	5.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HES1—brain cancer	2.82e-05	5.41e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—MYC—brain cancer	2.82e-05	5.4e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—STAT3—brain cancer	2.8e-05	5.37e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—RELA—brain cancer	2.8e-05	5.37e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—STAT3—brain cancer	2.8e-05	5.37e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL2—brain cancer	2.79e-05	5.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—IL2—brain cancer	2.79e-05	5.34e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—ERBB2—brain cancer	2.78e-05	5.34e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—APC—brain cancer	2.78e-05	5.33e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CG—brain cancer	2.78e-05	5.33e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—brain cancer	2.78e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMO—brain cancer	2.77e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTCH1—brain cancer	2.77e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—EGFR—brain cancer	2.76e-05	5.29e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CCND1—brain cancer	2.72e-05	5.22e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CTNNB1—brain cancer	2.7e-05	5.17e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CTNNB1—brain cancer	2.69e-05	5.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PDGFRA—brain cancer	2.69e-05	5.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—brain cancer	2.62e-05	5.02e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—STAT3—brain cancer	2.62e-05	5.02e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SPP1—brain cancer	2.61e-05	5e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MYC—brain cancer	2.6e-05	4.99e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MYC—brain cancer	2.6e-05	4.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HES1—brain cancer	2.6e-05	4.98e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RELA—brain cancer	2.59e-05	4.96e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—ERBB2—brain cancer	2.57e-05	4.93e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—APC—brain cancer	2.55e-05	4.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CG—brain cancer	2.55e-05	4.9e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EGFR—brain cancer	2.55e-05	4.88e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EGFR—brain cancer	2.54e-05	4.88e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MYC—brain cancer	2.54e-05	4.88e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL2—brain cancer	2.52e-05	4.84e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CTNNB1—brain cancer	2.48e-05	4.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PDGFRA—brain cancer	2.47e-05	4.74e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CCND1—brain cancer	2.46e-05	4.72e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CTNNB1—brain cancer	2.44e-05	4.67e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MYC—brain cancer	2.43e-05	4.66e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RELA—brain cancer	2.42e-05	4.64e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—ERBB2—brain cancer	2.4e-05	4.61e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EGFR—brain cancer	2.38e-05	4.56e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—brain cancer	2.37e-05	4.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—brain cancer	2.37e-05	4.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IRS2—brain cancer	2.36e-05	4.52e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—STAT3—brain cancer	2.35e-05	4.51e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—STAT3—brain cancer	2.35e-05	4.5e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL2—brain cancer	2.33e-05	4.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERBB2—brain cancer	2.31e-05	4.43e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—brain cancer	2.27e-05	4.35e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CTNNB1—brain cancer	2.25e-05	4.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH2—brain cancer	2.22e-05	4.25e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—brain cancer	2.18e-05	4.19e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—brain cancer	2.18e-05	4.18e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL2—brain cancer	2.18e-05	4.18e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RELA—brain cancer	2.17e-05	4.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IRS2—brain cancer	2.17e-05	4.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—brain cancer	2.16e-05	4.15e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—STAT3—brain cancer	2.16e-05	4.14e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ERBB2—brain cancer	2.16e-05	4.14e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—brain cancer	2.14e-05	4.11e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—brain cancer	2.14e-05	4.1e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—brain cancer	2.14e-05	4.1e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—brain cancer	2.13e-05	4.09e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—STAT3—brain cancer	2.12e-05	4.07e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—brain cancer	2.12e-05	4.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VAV1—brain cancer	2.11e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CTNNB1—brain cancer	2.1e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APC—brain cancer	2.08e-05	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CG—brain cancer	2.08e-05	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—brain cancer	2.02e-05	3.87e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—brain cancer	2.01e-05	3.85e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RELA—brain cancer	2e-05	3.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—brain cancer	1.98e-05	3.8e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—brain cancer	1.98e-05	3.8e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—brain cancer	1.97e-05	3.78e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—brain cancer	1.96e-05	3.77e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—brain cancer	1.96e-05	3.76e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—brain cancer	1.96e-05	3.75e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—brain cancer	1.93e-05	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APC—brain cancer	1.92e-05	3.68e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—brain cancer	1.91e-05	3.66e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—brain cancer	1.89e-05	3.62e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—brain cancer	1.85e-05	3.55e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—brain cancer	1.83e-05	3.52e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—brain cancer	1.82e-05	3.49e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HES1—brain cancer	1.82e-05	3.49e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—brain cancer	1.8e-05	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—brain cancer	1.79e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—brain cancer	1.79e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—brain cancer	1.78e-05	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—brain cancer	1.76e-05	3.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—brain cancer	1.76e-05	3.38e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—brain cancer	1.75e-05	3.36e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—brain cancer	1.74e-05	3.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDGFRA—brain cancer	1.73e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—brain cancer	1.7e-05	3.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SPP1—brain cancer	1.68e-05	3.22e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—brain cancer	1.67e-05	3.19e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—brain cancer	1.66e-05	3.19e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—brain cancer	1.65e-05	3.16e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—brain cancer	1.64e-05	3.14e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RELA—brain cancer	1.63e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—brain cancer	1.62e-05	3.11e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—brain cancer	1.62e-05	3.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—brain cancer	1.6e-05	3.07e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—brain cancer	1.53e-05	2.93e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—brain cancer	1.53e-05	2.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IRS2—brain cancer	1.52e-05	2.91e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—brain cancer	1.51e-05	2.9e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—brain cancer	1.5e-05	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—brain cancer	1.5e-05	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—brain cancer	1.49e-05	2.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—brain cancer	1.47e-05	2.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—brain cancer	1.43e-05	2.74e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—brain cancer	1.41e-05	2.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—brain cancer	1.41e-05	2.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—brain cancer	1.4e-05	2.68e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—brain cancer	1.37e-05	2.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APC—brain cancer	1.34e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CG—brain cancer	1.34e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—brain cancer	1.3e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—brain cancer	1.26e-05	2.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—brain cancer	1.25e-05	2.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—brain cancer	1.23e-05	2.37e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—brain cancer	1.15e-05	2.21e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—brain cancer	1.15e-05	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—brain cancer	1.14e-05	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—brain cancer	1.13e-05	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—brain cancer	1.12e-05	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—brain cancer	1.05e-05	2.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RELA—brain cancer	1.05e-05	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—brain cancer	1.04e-05	2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—brain cancer	1.03e-05	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—brain cancer	9.44e-06	1.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—brain cancer	9.41e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—brain cancer	9.21e-06	1.77e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—brain cancer	9.12e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—brain cancer	8.03e-06	1.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—brain cancer	7.95e-06	1.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—brain cancer	7.38e-06	1.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—brain cancer	7.22e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—brain cancer	6.06e-06	1.16e-05	CbGpPWpGaD
